SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: pincus who wrote (11492)9/12/2012 3:16:24 PM
From: LT2011  Read Replies (2) | Respond to of 13111
 
Pincus this is a very difficult place to be right now as a stockholder. As much as one wants to believe in PVCT, it's becoming increasingly hard to sit and wait.

The new short numbers are out this evening or tomorrow morning. I'm very anxious to see the numbers. It's been my opinion for awhile (although not shared) that the shorts is comprised of 1 or 2 players only. I would also venture to guess that they are the current buyers at these low prices.

JMO



To: pincus who wrote (11492)9/13/2012 9:56:41 AM
From: Howard Williams  Read Replies (1) | Respond to of 13111
 
pincus, I agree PVCT doesn't have the SPA and they need it before they can start the Phase III melanoma trial.

And I agree touching 65¢ is not good but I've been in several small biotechs over the last forty years and obsessing over moves like PVCT is seeing is (IMO) a serious waste of time. It's the 50% and 80% moves (in both directions) that deserve serious attention.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News